Wightman EL, Jackson PA, Spittlehouse B, Heffernan T, Guillemet D, Kennedy DO
Each additive targets slightly different aspects of tolerability and effectiveness
There is also emerging research for Akkermansias ability to reduce the prevalence of prediabetes, stimulate GLP-1 production, regulate liver enzyme activity, and diversify the gut microbiome through supplementation, highlighting its immense range of promising potential applications
Comparisons of metabolite levels between individuals with autism and typically developed (TD) Glu levels were significantly increased in the ACC in adults with autism compared to TD subjects (12.93 [1.27] for the autism group, 12.07 [1.26] for the TD group, t = 2.08, p = 0.045), Gln (2.97 [0.39] for the autism group, 2.70 [0.41] for the TD group, t = 2.09, p = 0.044), and mI (8.42 [1.03] for the autism group, 7.57 [1.27] for the TD group